DNAJC15 and metabolic dysfunction-associated steatohepatitis: LNP-siRNA targeting MCJ (LNP-siMCJ) was shown to result in reduced lipid accumulation, fibrosis, and hepatocyte damage in several NASH models mimicking different disease conditions.290